AMICUS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 - Other Events

On December 3, 2021, Amicus Therapeutics, Inc. (the "Company") issued a press release announcing that the European Medicines Agency validated the Marketing Authorization Applications for AT-GAA, the Company's investigational two-component therapy for the treatment of Pompe disease. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:



   Exhibit No.                               Description
      99.1            Press Release dated December 3, 2021
                    Cover Page Interactive Data File (embedded within the Inline
       104          XBRL document)

© Edgar Online, source Glimpses